<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR125">
 <label>125.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Clemens</surname>
    <given-names>DL</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>B-Y</given-names>
   </name>
   <name>
    <surname>Plamthottam</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Tullius</surname>
    <given-names>MV</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>C-J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Nanoparticle formulation of moxifloxacin and intramuscular route of delivery improve antibiotic pharmacokinetics and treatment of pneumonic tularemia in a mouse model</article-title>
  <source>ACS Infect Dis.</source>
  <year>2019</year>
  <volume>5</volume>
  <issue>2</issue>
  <fpage>281</fpage>
  <lpage>291</lpage>
  <pub-id pub-id-type="doi">10.1021/acsinfecdis.8b00268</pub-id>
  <?supplied-pmid 30480992?>
  <pub-id pub-id-type="pmid">30480992</pub-id>
 </element-citation>
</ref>
